NIM
NEOS Investment Management Portfolio holdings
AUM
$8.08B
1-Year Return
24.46%
This Quarter Return
+13.42%
1 Year Return
+24.46%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$1.61B
AUM Growth
+$558M
(+53%)
Cap. Flow
+$460M
Cap. Flow
% of AUM
28.51%
Top 10 Holdings %
Top 10 Hldgs %
34.09%
Holding
582
New
73
Increased
454
Reduced
38
Closed
16
Top Buys
| 1 |
Microsoft
MSFT
|
$30.2M |
| 2 |
Apple
AAPL
|
$24.8M |
| 3 |
NVIDIA
NVDA
|
$24.2M |
| 4 |
Amazon
AMZN
|
$18.3M |
| 5 |
Meta Platforms (Facebook)
META
|
$11.2M |
Top Sells
| 1 |
Vanguard Russell 2000 ETF
VTWO
|
$12.5M |
| 2 |
SPLK
Splunk Inc
SPLK
|
$848K |
| 3 |
Goldman Sachs
GS
|
$627K |
| 4 |
Travelers Companies
TRV
|
$553K |
| 5 |
IMGN
Immunogen Inc
IMGN
|
$523K |
Sector Composition
| 1 | Technology | 34.78% |
| 2 | Healthcare | 14.59% |
| 3 | Communication Services | 10.45% |
| 4 | Consumer Discretionary | 10.42% |
| 5 | Financials | 8.58% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
376
Eversource Energy
ES
$23.6B
| $516K | 0.03% |
8,632
+3,675
| +74% | +$220K |
|
377
Dover
DOV
$24.4B
| $512K | 0.03% |
2,892
+908
| +46% | +$161K |
|
378
Entergy
ETR
$39.2B
| $511K | 0.03% |
9,662
+3,662
| +61% | +$194K |
|
379
CRISPR Therapeutics
CRSP
$4.99B
| $510K | 0.03% |
7,486
+220
| +3% | +$15K |
|
380
Huntington Bancshares
HBAN
$25.7B
| $505K | 0.03% |
36,176
+15,629
| +76% | +$218K |
|
381
NetApp
NTAP
$23.7B
| $503K | 0.03% |
4,791
+1,830
| +62% | +$192K |
|
382
Western Digital
WDC
$31.9B
| $500K | 0.03% |
9,695
+3,630
| +60% | +$187K |
|
383
Celldex Therapeutics
CLDX
$1.52B
| $500K | 0.03% |
11,910
+350
| +3% | +$14.7K |
|
384
Revolution Medicines
RVMD
$7.57B
| $496K | 0.03% |
15,384
+4,480
| +41% | +$144K |
|
385
FirstEnergy
FE
$25.1B
| $496K | 0.03% |
12,831
+5,515
| +75% | +$213K |
|
386
SiriusXM
SIRI
$8.1B
| $495K | 0.03% |
12,750
+187
| +1% | +$7.26K |
|
387
PTC
PTC
$25.6B
| $491K | 0.03% |
2,597
+913
| +54% | +$173K |
|
388
PPL Corp
PPL
$26.6B
| $491K | 0.03% |
17,821
+7,344
| +70% | +$202K |
|
389
Neurocrine Biosciences
NBIX
$14.3B
| $490K | 0.03% |
+3,552
| New | +$490K |
|
390
Regions Financial
RF
$24.1B
| $490K | 0.03% |
23,280
+10,115
| +77% | +$213K |
|
|
BPMC
391
DELISTED
Blueprint Medicines
BPMC
| $487K | 0.03% |
5,134
+150
| +3% | +$14.2K |
|
392
Las Vegas Sands
LVS
$36.9B
| $487K | 0.03% |
9,418
+2,723
| +41% | +$141K |
|
393
Invitation Homes
INVH
$18.5B
| $485K | 0.03% |
13,633
+5,503
| +68% | +$196K |
|
394
Rio Tinto
RIO
$104B
| $485K | 0.03% |
7,616
+4,080
| +115% | +$260K |
|
395
Ball Corp
BALL
$13.9B
| $481K | 0.03% |
7,140
+2,745
| +62% | +$185K |
|
396
MGM Resorts International
MGM
$9.98B
| $476K | 0.03% |
10,078
+2,753
| +38% | +$130K |
|
397
Deckers Outdoor
DECK
$17.9B
| $474K | 0.03% |
+3,024
| New | +$474K |
|
398
Keysight
KEYS
$28.9B
| $474K | 0.03% |
3,029
+894
| +42% | +$140K |
|
399
APi Group
APG
$14.5B
| $470K | 0.03% |
17,967
+5,763
| +47% | +$151K |
|
400
Gartner
IT
$18.6B
| $463K | 0.03% |
972
-18
| -2% | -$8.58K |
|